StockVS

NASDAQ · Medical Devices · USD

UFP Technologies, Inc. (UFPT) Stock Analysis

UFP Technologies, Inc. (UFPT) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

UFPT

$288.79

+$2.27 (+0.79%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare UFPT with… →

UFPT Key Statistics

As of Sep 4, 2026
Trading
Open
$285.00
Previous Close
$286.52
Day's Range
285.00–290.46
52-Week Range
173.86–338.71
Volume
105.30K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.07
Valuation
Market Cap
$2.24B
P/E Ratio
31.19
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
24.32
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
3.80
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
3.54
EPS (ttm)Profit attributable to each share over the last twelve months.
9.26
Financials (FY)
Revenue (FY)
$602.80M+19.50%
Net Income (FY)
$68.31M+15.82%
Profit marginThe share of revenue left as profit after all costs and taxes.
11.45%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
7.75M
1-Year Return
+38.28%
Dividend and dates
Earnings Date
November 2, 2026
Avg Volume
193.09K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

UFPT Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+30.07%
2025−9.19%
2024+42.12%
2023+45.93%
2022+67.79%
2021+50.77%
2020−6.07%
2019+65.15%
2018+8.06%
2017+9.23%
2016 (partial year)+7.61%

As of September 4, 2026.

UFPT Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$602.80M$68.31M11.3%
2024$504.42M$58.98M11.7%
2023$400.07M$44.92M11.2%
2022$353.79M$41.79M11.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$602.80M$170.41M$92.97M$68.31M11.3%
2024$504.42M$146.69M$84.48M$58.98M11.7%
2023$400.07M$112.23M$61.34M$44.92M11.2%
2022$353.79M$90.26M$44.46M$41.79M11.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

UFPT Valuation vs Medical Devices Median

Median of 151 stocks
MetricUFPTMedical Devices medianvs median
P/E31.1926.8016% above
P/S ratio3.542.9819% above
Profit margin11.45%−1.69%13.1 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 8 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

UFP Technologies, Inc. (UFPT) carries a market capitalisation of $2.24B. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 4,846 employees.

The most recent close on file for UFPT is $288.79, dated September 4, 2026. That is +$2.27 (+0.79%) against the previous close. Over the past 52 weeks the price has ranged from $173.86 to $338.71. The latest close sits 66.1% above that 52-week low.

Financial Health

In fiscal 2025, UFP Technologies, Inc. reported revenue of $602.80M. Against the prior fiscal year total of $504.42M, that is a change of +19.50%. Net income for the same year was $68.31M. That is +15.82% against the prior fiscal year. Profit margin runs at 11.45%. That is 13.1 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are 9.26.

Across the 4 fiscal years on file, revenue moves from $353.79M in 2022 to $602.80M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 31.19. That is 16.38% above the Medical Devices median of 26.8. On forward earnings the ratio is 24.32. The PEG ratio, which sets the P/E against expected earnings growth, reads 3.8. Measured against sales, the shares trade at 3.54 times revenue. On price-to-sales that is 19% above the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

Over the trailing twelve months the price has returned +38.28%. Across 10 years the annualized return works out at +27.59%. The reported beta is 1.07. Daily returns over the trailing 10 years annualize to a volatility of 40.61%.

Growth & Income

No dividend is on file for UFPT.

So far in 2026 the price is +30.07%. Across the complete calendar years on file, 2022 returned +67.79% and 2025 returned −9.19%. Of the 9 complete calendar years on file, 7 finished higher.

Peer Comparison

UFP Technologies, Inc. (UFPT) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
UFP Technologies, Inc. UFPT $2.24B 31.2
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. UFP Technologies, Inc. trades at a P/E of 31.2.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

View all Medical Devices stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About UFP Technologies, Inc.

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment protection and packaging for firearms, unmanned aerial vehicles/drones, weapon systems, electronic devices communications equipment, and tools and repair kits; cushion and protective packaging; acoustic and thermal insulation components for automotive, aerospace, consumer, and industrial; filtration for small engines, air conditioners, humidifiers, refrigerators, electronic air cleaners, forced air appliances and industrial compressors; fluid management; and seals and gaskets for automotive manufacturing chemical processing, building and construction applications. In addition, the company provides uniform and tactical gear, such as backpack straps and padding, uniform knee and elbow pads, duty belts, holsters, and helmet padding and others; sports and leisure including custom helmet linings, athletic braces, and shoe insoles; and trim and structural components, consist of load floors, sunshades, package trays, back panel, and seat backs. The company serves the medical, aerospace and defence, automotive, consumer, electronics, and industrial markets. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.

Visit website →